University of Ioannina
Επιδημιολογική και ανοσολογική μελέτη ασθενών με γλοιώματα του ΚΝΣ
Abstract
dc:descriptionAim: To investigate the cellular and humoral immunity status of gliomas, and their association with the WHO grading system and Overall Survival. Material and Methods: We have conducted a case-control study of 49 patients with gliomas and 30 healthy controls referred to the University Hospital of Ioannina. Blood sample was undertaken preoperative. We used ELISA assays to estimate IL2, IL10, IL16, TNF-a, granzyme-b, IgM, IgG, IgA, IgE, CMV IgM and IgG, EBV IgM and IgG, and toxoplasma gondii IgM and IgG. In addition, we evaluated C3 and C4 complement (radial immunodiffusion), ANA (indirect immunofluorescence), RF (Latex test), ENA (ELISA and line immunoassay), anti-dsDNA (ELISA), and anti-cardiolipin antibodies (ELISA). Flow cytometry was performed to measure CD3, CD4, CD8, CD19, CD16+56 positive cells and ratio CD4/CD8. Results: Patients with glioma had significantly reduced amounts of IL2 (p=0.000), TNFa (p=0.033), IgG(p=0.011), IgA(p=0.027), C4 (p=0.026), CD3 (p=0.001), CD4 (p=0.000), CD8 (p=0.002), ratio CD4/CD8 (p=0.000), CD19 (p=0.04) and elevated IL10 (p=0.05) compared with healthy controls. No statistically significant differences were observed concerning viral agents, total NK-cells, IgM, IL16, granzyme-b, RF, ANA, ENA, anti-dsDNA and anti-cardiolipin antibodies. A higher WHO grade was associated with decreased number of CD3 (p=0.011), CD4 (p=0.015), CD8 (p=0.048) and ratio CD4/CD8 (p=0.027), as well as with decreased IL2 (p=0.018), C4 (p=0.02), and IgG (p=0.05). CD4 counts and IL2 values are independent significant predictors of WHO grade. Beneficial prognostic factors are younger age at diagnosis (p=0.020), surgical resection vs biopsy (p=0.042), adjuvant chemo (p=0.028) and radiotherapy (p=0.002) and CD4 counts over 200 /mm3 (p=0.001). Various interactions between the counterparts of the immune system were revealed. CD4 counts over 200 /mm3 is a independent beneficial prognostic factor of overall survival. Conclusions: A shift from Th1 to Th2, a CD3 and CD19 lymphocytopenia, a diminished fraction CD4/CD8 and a reduced amount of immunoglobulins and complement were observed in the patients with gliomas. A higher WHO grade of the tumor was associated with greater impairments of immunity. CD4 counts and IL2 values are independent significant predictors of WHO grade.CD4 counts correlate inversely with a better outcome of patients with GBM. Defects of the humoral and cellular immunity were equally observed. A preoperative evaluation of the immune system of patients with gliomas is being proposed.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Gousias, Konstantinos
- Γούσιας, Κωνσταντίνος
Subjects
dc:subject × 18- Γλοιώματα, Επίπτωση
- Γλοιωματογένεση, Προδιαθεσικοί παράγοντες
- Ανοσολογικό σύστημα
- WHO, Βαθμός κακοήθειας κατά
- Προγνωστικοί παράγοντες επιβίωσης
- CD4 κύτταρα, Αριθμός
- Ιντερλευκίνη-2
- WHO, Προεγχειρητική πρόβλεψη του grade κατά
- Incidence rate of gliomas
- Predisposing factors of gliomagenesis
- Impairments of immunological system
- CD4 cells counts
- IL-2
- Preoperative predictors of WHO grade
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19727